Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Pharmacoeconomics
|
August 18, 2000
ACE inhibitors after myocardial infarction. Clinical and economic considerations
A P Davie
Postgraduate Medical Journal
|
March 15, 2000
ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?
A P Davie, J J McMurray
Hypertension (Dallas, Tex. : 1979)
|
September 18, 1999
Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor
A P Davie, J J McMurray
Coronary Artery Disease
|
April 1, 1995
ACE inhibitors and health-care economics
A P Davie, J J McMurray
Circulation
|
July 21, 1999
Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure
A P Davie, H J Dargie, J J McMurray
Journal of the American College of Cardiology
|
April 13, 2001
Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure
P S Jhund, A P Davie, J J McMurray
Clinical Pharmacology and Therapeutics
|
May 29, 2000
Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure
A P Davie, M P Love, J J McMurray
European Heart Journal
|
February 12, 1998
Cost-effectiveness of different ACE inhibitor treatment scenarios post-myocardial infarction
J J McMurray, A McGuire, A P Davie, et al.
BMJ (Clinical Research Ed.)
|
July 21, 2000
Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study
L Caruana, M C Petrie, A P Davie, et al.
European Heart Journal
|
January 14, 1999
Clinical epidemiology of heart failure: public and private health burden
J J McMurray, M C Petrie, D R Murdoch, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Pharmacoeconomics
|
August 18, 2000
ACE inhibitors after myocardial infarction. Clinical and economic considerations
A P Davie
Postgraduate Medical Journal
|
March 15, 2000
ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?
A P Davie, J J McMurray
Hypertension (Dallas, Tex. : 1979)
|
September 18, 1999
Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor
A P Davie, J J McMurray
Coronary Artery Disease
|
April 1, 1995
ACE inhibitors and health-care economics
A P Davie, J J McMurray
Circulation
|
July 21, 1999
Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure
A P Davie, H J Dargie, J J McMurray
Journal of the American College of Cardiology
|
April 13, 2001
Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure
P S Jhund, A P Davie, J J McMurray
Clinical Pharmacology and Therapeutics
|
May 29, 2000
Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure
A P Davie, M P Love, J J McMurray
European Heart Journal
|
February 12, 1998
Cost-effectiveness of different ACE inhibitor treatment scenarios post-myocardial infarction
J J McMurray, A McGuire, A P Davie, et al.
BMJ (Clinical Research Ed.)
|
July 21, 2000
Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study
L Caruana, M C Petrie, A P Davie, et al.
European Heart Journal
|
January 14, 1999
Clinical epidemiology of heart failure: public and private health burden
J J McMurray, M C Petrie, D R Murdoch, et al.
Page
of 2